Literature DB >> 8641688

Geographic distribution and origin of CFTR mutations in Germany.

B Tümmler1, T Storrs, V Dziadek, T Dörk, T Meitinger, A Golla, R M Bertele-Harms, H K Harms, E Schröder, A Claass, J Rutjes, R Schneppenheim, I Bauer, K Breuel, M Stuhrmann, J Schmidtke, M Lindner, A Eigel, J Horst, R Kaiser, M J Lentze, K Schmidt, H von der Hardt, X Estivill.   

Abstract

The geographic distribution and origin of CFTR mutations in Germany was evaluated in 658 three-generation families with cystic fibrosis (CF). Fifty different mutations were detected on 1305 parental CF chromosomes from 22 European countries and overseas. The major mutation. delta F508 was identified on 71.5% of all CF chromosomes, followed by R553X (1.8%), N1303K (1.3%), G542X (1.1%), G551D (0.8%) and R347P (0.8%). According to the grandparents' birthplace, 74% of CF chromosomes had their origin in Germany; the delta F508 percentage was 77%, 75%, 70% and 62% in northern, southern, western and eastern Germany, respectively. Ten or more mutant alleles in the investigated CF gene pool originated from Austria, the Czech Republic, Poland, Russia, Turkey and the Ukraine. This widespread geographic origin of CFTR mutations in today's Germany reflects the many demographic changes and migrations in Central Europe during the 20th century.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8641688     DOI: 10.1007/bf02346181

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  6 in total

1.  Severe splice site mutation preceding exon 9 of the CFTR gene.

Authors:  T Dörk; R Fislage; U Rappen; B Tümmler
Journal:  Hum Mol Genet       Date:  1993-08       Impact factor: 6.150

2.  Identification of the cystic fibrosis gene: genetic analysis.

Authors:  B Kerem; J M Rommens; J A Buchanan; D Markiewicz; T K Cox; A Chakravarti; M Buchwald; L C Tsui
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

3.  Association of a nonsense mutation (W1282X), the most common mutation in the Ashkenazi Jewish cystic fibrosis patients in Israel, with presentation of severe disease.

Authors:  T Shoshani; A Augarten; E Gazit; N Bashan; Y Yahav; Y Rivlin; A Tal; H Seret; L Yaar; E Kerem
Journal:  Am J Hum Genet       Date:  1992-01       Impact factor: 11.025

4.  Population variation of common cystic fibrosis mutations. The Cystic Fibrosis Genetic Analysis Consortium.

Authors: 
Journal:  Hum Mutat       Date:  1994       Impact factor: 4.878

5.  First analysis of the F508 deletion in cystic fibrosis patients from the GDR.

Authors:  K Grade; K Will; R Szibor; J Gedschold; R Brückner; I Bauer; K Giermann; H Gorki; J Hein; U Brell
Journal:  Hum Genet       Date:  1990-09       Impact factor: 4.132

6.  A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations.

Authors:  W E Highsmith; L H Burch; Z Zhou; J C Olsen; T E Boat; A Spock; J D Gorvoy; L Quittel; K J Friedman; L M Silverman
Journal:  N Engl J Med       Date:  1994-10-13       Impact factor: 91.245

  6 in total
  3 in total

1.  Initial evaluation of a biochemical cystic fibrosis newborn screening by sequential analysis of immunoreactive trypsinogen and pancreatitis-associated protein (IRT/PAP) as a strategy that does not involve DNA testing in a Northern European population.

Authors:  Olaf Sommerburg; Martin Lindner; Martina Muckenthaler; Dirk Kohlmueller; Svenja Leible; Reinhard Feneberg; Andreas E Kulozik; Marcus A Mall; Georg F Hoffmann
Journal:  J Inherit Metab Dis       Date:  2010-08-17       Impact factor: 4.982

2.  Liver Failure in a Chinese Cystic Fibrosis Child With Homozygous R553X Mutation.

Authors:  Haiyan Li; Li Lin; Xiaoguang Hu; Changchong Li; Hailin Zhang
Journal:  Front Pediatr       Date:  2019-02-20       Impact factor: 3.418

3.  The basidiomycetous yeast Trichosporon may cause severe lung exacerbation in cystic fibrosis patients - clinical analysis of Trichosporon positive patients in a Munich cohort.

Authors:  Carolin Kröner; Matthias Kappler; Ann-Christin Grimmelt; Gudrun Laniado; Benjamin Würstl; Matthias Griese
Journal:  BMC Pulm Med       Date:  2013-11-01       Impact factor: 3.317

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.